Vertex Pharmaceuticals Incorporated (VRTX)
USD 478.23
(-1.19%)
USD 478.23
(-1.19%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 724.7 Million USD | 53.67% |
| 2022 | 471.6 Million USD | -15.29% |
| 2021 | 556.7 Million USD | -4.26% |
| 2020 | 581.47 Million USD | 0.71% |
| 2019 | 577.37 Million USD | 1.8% |
| 2018 | 567.16 Million USD | 0.58% |
| 2017 | 563.91 Million USD | -32.73% |
| 2016 | 838.24 Million USD | 2.15% |
| 2015 | 820.61 Million USD | -0.57% |
| 2014 | 825.29 Million USD | 87.17% |
| 2013 | 440.93 Million USD | -34.45% |
| 2012 | 672.63 Million USD | 68.16% |
| 2011 | 400 Million USD | 0.0% |
| 2010 | 400 Million USD | 160.02% |
| 2009 | 153.83 Million USD | -46.49% |
| 2008 | 287.5 Million USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 19.99 Million USD | -88.9% |
| 2005 | 180.09 Million USD | -46.24% |
| 2004 | 334.99 Million USD | -1.68% |
| 2003 | 340.72 Million USD | 4.54% |
| 2002 | 325.94 Million USD | 0.9% |
| 2001 | 323.02 Million USD | -6.99% |
| 2000 | 347.31 Million USD | 7289.64% |
| 1999 | 4.7 Million USD | -32.86% |
| 1998 | 7 Million USD | 18.64% |
| 1997 | 5.9 Million USD | 5.36% |
| 1996 | 5.6 Million USD | 14.29% |
| 1995 | 4.9 Million USD | 4.26% |
| 1994 | 4.7 Million USD | 11.9% |
| 1993 | 4.2 Million USD | 27.27% |
| 1992 | 3.3 Million USD | 57.14% |
| 1991 | 2.1 Million USD | -12.5% |
| 1990 | 2.4 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 721.3 Million USD | -0.47% |
| 2024 Q3 | 1.7 Billion USD | -100.0% |
| 2024 Q2 | 933.4 Million USD | 29.41% |
| 2023 FY | 724.7 Million USD | 53.67% |
| 2023 Q1 | 789.2 Million USD | 67.35% |
| 2023 Q3 | 744.7 Million USD | -2.98% |
| 2023 Q4 | 724.7 Million USD | -2.69% |
| 2023 Q2 | 767.6 Million USD | -2.74% |
| 2022 FY | 471.6 Million USD | -15.29% |
| 2022 Q4 | 471.6 Million USD | -2.16% |
| 2022 Q3 | 482 Million USD | -9.33% |
| 2022 Q2 | 531.6 Million USD | -2.32% |
| 2022 Q1 | 544.2 Million USD | -2.25% |
| 2021 Q1 | 572.85 Million USD | -1.48% |
| 2021 Q2 | 569.75 Million USD | -0.54% |
| 2021 Q3 | 558.93 Million USD | -1.9% |
| 2021 Q4 | 556.7 Million USD | -0.4% |
| 2021 FY | 556.7 Million USD | -4.26% |
| 2020 Q2 | 562.47 Million USD | -1.82% |
| 2020 Q4 | 581.47 Million USD | -1.07% |
| 2020 Q1 | 572.91 Million USD | -0.77% |
| 2020 FY | 581.47 Million USD | 0.71% |
| 2020 Q3 | 587.77 Million USD | 4.5% |
| 2019 Q3 | 578.62 Million USD | -1.69% |
| 2019 Q2 | 588.57 Million USD | -1.26% |
| 2019 Q1 | 596.1 Million USD | 5.1% |
| 2019 Q4 | 577.37 Million USD | -0.22% |
| 2019 FY | 577.37 Million USD | 1.8% |
| 2018 FY | 567.16 Million USD | 0.58% |
| 2018 Q4 | 567.16 Million USD | 0.25% |
| 2018 Q3 | 565.74 Million USD | -0.77% |
| 2018 Q2 | 570.12 Million USD | 0.46% |
| 2018 Q1 | 567.49 Million USD | 0.64% |
| 2017 Q2 | 525.54 Million USD | 5.26% |
| 2017 Q3 | 547.54 Million USD | 4.19% |
| 2017 Q4 | 563.91 Million USD | 2.99% |
| 2017 FY | 563.91 Million USD | -32.73% |
| 2017 Q1 | 499.28 Million USD | -40.44% |
| 2016 Q1 | 824.94 Million USD | 0.53% |
| 2016 Q2 | 821.09 Million USD | -0.47% |
| 2016 Q3 | 815.74 Million USD | -0.65% |
| 2016 FY | 838.24 Million USD | 2.15% |
| 2016 Q4 | 838.24 Million USD | 2.76% |
| 2015 Q3 | 820.98 Million USD | -0.42% |
| 2015 Q2 | 824.46 Million USD | -1.13% |
| 2015 Q1 | 833.9 Million USD | 1.04% |
| 2015 Q4 | 820.61 Million USD | -0.04% |
| 2015 FY | 820.61 Million USD | -0.57% |
| 2014 Q2 | 473.26 Million USD | -0.02% |
| 2014 Q4 | 825.29 Million USD | 7.47% |
| 2014 Q1 | 473.36 Million USD | 7.35% |
| 2014 FY | 825.29 Million USD | 87.17% |
| 2014 Q3 | 767.91 Million USD | 62.26% |
| 2013 Q4 | 440.93 Million USD | 12.32% |
| 2013 Q1 | 716.82 Million USD | 6.57% |
| 2013 FY | 440.93 Million USD | -34.45% |
| 2013 Q2 | 359.1 Million USD | -49.9% |
| 2013 Q3 | 392.56 Million USD | 9.32% |
| 2012 Q1 | 400 Million USD | 0.0% |
| 2012 Q3 | 400 Million USD | 0.0% |
| 2012 Q4 | 672.63 Million USD | 68.16% |
| 2012 FY | 672.63 Million USD | 68.16% |
| 2012 Q2 | 400 Million USD | 0.0% |
| 2011 FY | 400 Million USD | 0.0% |
| 2011 Q4 | 400 Million USD | 0.0% |
| 2011 Q3 | 400 Million USD | 0.0% |
| 2011 Q2 | 400 Million USD | 0.0% |
| 2011 Q1 | 400 Million USD | 0.0% |
| 2010 Q3 | 400 Million USD | 362.93% |
| 2010 Q2 | 86.4 Million USD | -31.05% |
| 2010 Q1 | 125.31 Million USD | 2.92% |
| 2010 Q4 | 400 Million USD | 0.0% |
| 2010 FY | 400 Million USD | 160.02% |
| 2009 FY | 153.83 Million USD | -46.49% |
| 2009 Q1 | 287.5 Million USD | 0.0% |
| 2009 Q2 | 144 Million USD | -49.91% |
| 2009 Q3 | 144 Million USD | 0.0% |
| 2009 Q4 | 121.76 Million USD | -15.44% |
| 2008 Q3 | 287.5 Million USD | 0.0% |
| 2008 Q4 | 287.5 Million USD | 0.0% |
| 2008 FY | 287.5 Million USD | 0.0% |
| 2008 Q1 | 287.5 Million USD | 0.0% |
| 2008 Q2 | 287.5 Million USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q2 | - USD | -100.0% |
| 2007 Q1 | 19.99 Million USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 FY | 19.99 Million USD | -88.9% |
| 2006 Q4 | 19.99 Million USD | -66.47% |
| 2006 Q2 | 180.09 Million USD | -0.0% |
| 2006 Q1 | 180.09 Million USD | 0.0% |
| 2006 Q3 | 59.64 Million USD | -66.88% |
| 2005 Q4 | 180.09 Million USD | -38.86% |
| 2005 FY | 180.09 Million USD | -46.24% |
| 2005 Q1 | 334.99 Million USD | 0.0% |
| 2005 Q2 | 334.99 Million USD | 0.0% |
| 2005 Q3 | 294.54 Million USD | -12.07% |
| 2004 FY | 334.99 Million USD | -1.68% |
| 2004 Q2 | 317.92 Million USD | 0.93% |
| 2004 Q1 | 315 Million USD | -7.55% |
| 2004 Q3 | 315 Million USD | -0.92% |
| 2004 Q4 | 334.99 Million USD | 6.35% |
| 2003 Q1 | 328.52 Million USD | 0.79% |
| 2003 FY | 340.72 Million USD | 4.54% |
| 2003 Q2 | 337.28 Million USD | 2.67% |
| 2003 Q3 | 340.49 Million USD | 0.95% |
| 2003 Q4 | 340.72 Million USD | 0.07% |
| 2002 Q4 | 325.94 Million USD | 1.44% |
| 2002 FY | 325.94 Million USD | 0.9% |
| 2002 Q3 | 321.31 Million USD | -0.13% |
| 2002 Q2 | 321.73 Million USD | -0.19% |
| 2002 Q1 | 322.33 Million USD | -0.22% |
| 2001 Q4 | 323.02 Million USD | -8.8% |
| 2001 Q3 | 354.18 Million USD | 2.18% |
| 2001 Q2 | 346.63 Million USD | -0.1% |
| 2001 Q1 | 346.96 Million USD | -0.1% |
| 2001 FY | 323.02 Million USD | -6.99% |
| 2000 FY | 347.31 Million USD | 7289.64% |
| 2000 Q1 | 179.15 Million USD | 3711.81% |
| 2000 Q2 | 178.61 Million USD | -0.3% |
| 2000 Q3 | 348.12 Million USD | 94.9% |
| 2000 Q4 | 347.31 Million USD | -0.23% |
| 1999 Q2 | 5.8 Million USD | -9.38% |
| 1999 FY | 4.7 Million USD | -32.86% |
| 1999 Q4 | 4.7 Million USD | -11.32% |
| 1999 Q1 | 6.4 Million USD | -8.57% |
| 1999 Q3 | 5.3 Million USD | -8.62% |
| 1998 Q4 | 7 Million USD | -7.89% |
| 1998 FY | 7 Million USD | 18.64% |
| 1998 Q1 | 6.2 Million USD | 5.08% |
| 1998 Q2 | 6.9 Million USD | 11.29% |
| 1998 Q3 | 7.6 Million USD | 10.14% |
| 1997 Q2 | 5.4 Million USD | 1.89% |
| 1997 Q3 | 5.5 Million USD | 1.85% |
| 1997 Q1 | 5.3 Million USD | -5.36% |
| 1997 Q4 | 5.9 Million USD | 7.27% |
| 1997 FY | 5.9 Million USD | 5.36% |
| 1996 FY | 5.6 Million USD | 14.29% |
| 1996 Q4 | 5.6 Million USD | 27.27% |
| 1996 Q1 | 4.4 Million USD | -10.2% |
| 1996 Q2 | 4.6 Million USD | 4.55% |
| 1996 Q3 | 4.4 Million USD | -4.35% |
| 1995 Q4 | 4.9 Million USD | 0.0% |
| 1995 FY | 4.9 Million USD | 4.26% |
| 1995 Q1 | 4.9 Million USD | 4.26% |
| 1995 Q2 | 5.1 Million USD | 4.08% |
| 1995 Q3 | 4.9 Million USD | -3.92% |
| 1994 Q3 | 4.7 Million USD | 6.82% |
| 1994 Q2 | 4.4 Million USD | 12.82% |
| 1994 FY | 4.7 Million USD | 11.9% |
| 1994 Q1 | 3.9 Million USD | -7.14% |
| 1994 Q4 | 4.7 Million USD | 0.0% |
| 1993 FY | 4.2 Million USD | 27.27% |
| 1993 Q1 | 3.4 Million USD | 3.03% |
| 1993 Q2 | 3.9 Million USD | 14.71% |
| 1993 Q3 | 4 Million USD | 2.56% |
| 1993 Q4 | 4.2 Million USD | 5.0% |
| 1992 Q2 | 2.9 Million USD | 26.09% |
| 1992 Q1 | 2.3 Million USD | 9.52% |
| 1992 Q3 | 3.3 Million USD | 13.79% |
| 1992 Q4 | 3.3 Million USD | 0.0% |
| 1992 FY | 3.3 Million USD | 57.14% |
| 1991 Q3 | 2.4 Million USD | -4.0% |
| 1991 FY | 2.1 Million USD | -12.5% |
| 1991 Q2 | 2.5 Million USD | 0.0% |
| 1991 Q4 | 2.1 Million USD | -12.5% |
| 1990 FY | 2.4 Million USD | 0.0% |
| 1990 Q4 | 2.4 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -917.523% |
| Alkermes plc | 287.73 Million USD | -151.868% |
| Agenus Inc. | 137.32 Million USD | -427.73% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 69.07% |
| Aptorum Group Limited | 3.05 Million USD | -23594.622% |
| Ardelyx, Inc. | 51.54 Million USD | -1305.901% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -592.777% |
| Bicycle Therapeutics plc | 40.08 Million USD | -1708.134% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -620.392% |
| ChromaDex Corporation | 2.57 Million USD | -28043.689% |
| Chimerix, Inc. | 125 Thousand USD | -579660.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -22276.739% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -2697.205% |
| CRISPR Therapeutics AG | 223 Million USD | -224.967% |
| Precision BioSciences, Inc. | 7.72 Million USD | -9283.659% |
| Dyadic International, Inc. | 88.87 Thousand USD | -815360.785% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -3293990.909% |
| Fortress Biotech, Inc. | 60.85 Million USD | -1090.844% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -1178350.631% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -18966.035% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -804014.331% |
| Incyte Corporation | 29.16 Million USD | -2385.083% |
| IO Biotech, Inc. | 1.83 Million USD | -39307.287% |
| Jaguar Health, Inc. | 30.99 Million USD | -2238.27% |
| Novavax, Inc. | 168.01 Million USD | -331.328% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -3047.448% |
| Opthea Limited | 200.53 Million USD | -261.382% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -12492.528% |
| ContextLogic Inc. | 6 Million USD | -11978.333% |
| MiMedx Group, Inc. | 48.09 Million USD | -1406.684% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -3505.652% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -1892511.841% |
| NextCure, Inc. | 5.94 Million USD | -12081.879% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -499693.103% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -3177.554% |
| PDS Biotechnology Corporation | 19.5 Million USD | -3615.232% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -527.555% |
| Pharming Group N.V. | 166.1 Million USD | -336.29% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -11564.252% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -2062.315% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -59991.211% |
| Acelyrin, Inc. | 1.19 Million USD | -60595.142% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -157443.478% |
| Summit Therapeutics Inc. | 103.29 Million USD | -601.617% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -19127.912% |
| Senti Biosciences, Inc. | 33.53 Million USD | -2060.832% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -15083.323% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -1997.176% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -1101.406% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -46059.236% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -2752.7% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -594.57% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -98902.732% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -6375.739% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -423.991% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -5292.514% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -4731.333% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -279.559% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -1276.239% |
| Fortress Biotech, Inc. | 60.85 Million USD | -1090.844% |
| Precigen, Inc. | 5.89 Million USD | -12193.469% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -1625.969% |
| AlloVir, Inc. | 16.64 Million USD | -4253.075% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -1002.088% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -644.351% |
| ImmuCell Corporation | 10.54 Million USD | -6775.388% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -64317.778% |
| Onconetix, Inc. | 118.85 Thousand USD | -609624.291% |
| PureTech Health plc | 18.25 Million USD | -3870.959% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -731920.202% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2304.685% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -2691.172% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -1590.302% |
| Innoviva, Inc. | 446.23 Million USD | -62.404% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -86898.8% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -1084066.118% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -250.151% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -917.894% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -22632.12% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -69716.956% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -3145.991% |
| Aptose Biosciences Inc. | 621 Thousand USD | -116598.873% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -71586.183% |
| Century Therapeutics, Inc. | 46.65 Million USD | -1453.217% |
| Kura Oncology, Inc. | 9.33 Million USD | -7665.752% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -2614.232% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -525044.928% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -7621.897% |
| Autolus Therapeutics plc | 47.91 Million USD | -1412.502% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -14671.708% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -10599.838% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -454.646% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -8841.394% |
| IGM Biosciences, Inc. | 34.67 Million USD | -1990.159% |
| INmune Bio, Inc. | 397 Thousand USD | -182444.081% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -317.086% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -17775.025% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -493064.295% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -1356.04% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -1228.019% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -1486.02% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -53.094% |
| Verastem, Inc. | 40.08 Million USD | -1707.863% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -16362.971% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -7108.076% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -10945.572% |
| Histogen Inc. | 4.38 Million USD | -16430.566% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -82065.533% |
| Organovo Holdings, Inc. | 888 Thousand USD | -81510.36% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -2315.667% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -17179.447% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -3735.406% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -857.332% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -778276.869% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -2697.313% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -271323.221% |
| Amarin Corporation plc | 8.73 Million USD | -8194.609% |
| Mesoblast Limited | 100.48 Million USD | -621.217% |
| Turnstone Biologics Corp. | 1.18 Million USD | -60850.378% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -825.2% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -664762.385% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -783.683% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -281.534% |
| Better Therapeutics, Inc. | 10.34 Million USD | -6903.286% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -3033.838% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -678.971% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -55991.331% |
| Gritstone bio, Inc. | 40.14 Million USD | -1705.251% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -39850.386% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -371.831% |
| Insmed Incorporated | 1.19 Billion USD | 39.272% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -11312.598% |
| OmniAb, Inc. | 22.07 Million USD | -3182.899% |
| Alector, Inc. | 30.45 Million USD | -2279.498% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -613.681% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -8905.841% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -69.88% |
| Aura Biosciences, Inc. | 16.87 Million USD | -4195.791% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -1173.772% |
| Immunic, Inc. | 639 Thousand USD | -113311.581% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -2330.33% |
| Veracyte, Inc. | 7.52 Million USD | -9530.565% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -12.38% |
| FibroGen, Inc. | 89.69 Million USD | -707.942% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -16609.707% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -553685.256% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 85.812% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1958548.649% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -36501.01% |
| TG Therapeutics, Inc. | 100.11 Million USD | -623.846% |
| Galecto, Inc. | 66 Thousand USD | -1097930.303% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -532767.647% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 55.605% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -11948.213% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -13327.83% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -39850.386% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -3279.027% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -1882.492% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -140074.081% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1502.043% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -2270.315% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -1517.562% |
| Vaxxinity, Inc. | 13.26 Million USD | -5364.485% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 10.67% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -161284.068% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -8145.534% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 73.188% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -229235.443% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -16156.169% |
| Ainos, Inc. | 5.92 Million USD | -12138.337% |
| Pluri Inc. | 29.05 Million USD | -2394.407% |
| Prothena Corporation plc | 10.72 Million USD | -6659.631% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -3550.698% |
| Celularity Inc. | 26.17 Million USD | -2668.461% |
| Rallybio Corporation | 173 Thousand USD | -418801.734% |
| Cue Biopharma, Inc. | 4.2 Million USD | -17146.549% |
| MeiraGTx Holdings plc | 72.11 Million USD | -904.867% |
| Omeros Corporation | 329.7 Million USD | -119.803% |
| Humacyte, Inc. | 38.6 Million USD | -1777.461% |
| Immunocore Holdings plc | 82.64 Million USD | -776.894% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -44828.704% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -20159.994% |
| Blueprint Medicines Corporation | 610.96 Million USD | -18.616% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -49605.075% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -661.327% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -1388.579% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -697.241% |
| Pulmatrix, Inc. | 8.32 Million USD | -8603.014% |
| Elicio Therapeutics, Inc. | 6 Million USD | -11964.258% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -5498.301% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -649.067% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -154420.256% |
| Cytokinetics, Incorporated | 607.37 Million USD | -19.317% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -8237.552% |
| Nutriband Inc. | 79.82 Thousand USD | -907749.573% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -16061.909% |
| Vor Biopharma Inc. | 31.83 Million USD | -2176.783% |
| Roivant Sciences Ltd. | 477.85 Million USD | -51.657% |
| Evogene Ltd. | 10.65 Million USD | -6702.779% |
| ProKidney Corp. | 3.61 Million USD | -19974.792% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -95380.896% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -2752691.917% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 58.248% |
| CorMedix Inc. | 517.01 Thousand USD | -140070.557% |
| BioLineRx Ltd. | 6.62 Million USD | -10833.917% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -1867.262% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -910.162% |
| Atai Life Sciences N.V. | 15.21 Million USD | -4664.315% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -85929.139% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -284096.078% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -1579.49% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -176372.021% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -52836.45% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -109189.865% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -306.975% |
| Biomea Fusion, Inc. | 7.83 Million USD | -9155.428% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -154.985% |
| Mereo BioPharma Group plc | 5.3 Million USD | -13573.585% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -33606.977% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -123148.299% |
| Absci Corporation | 4.66 Million USD | -15451.502% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -6189.707% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -3093.214% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -7143.378% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -6199.0% |
| Allakos Inc. | 38.21 Million USD | -1796.376% |
| Imunon, Inc. | 1.13 Million USD | -63509.625% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -8298.424% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -86586.603% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -7246900.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -720.297% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -15289.679% |
| XOMA Corporation | 118.51 Million USD | -511.468% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -7097.338% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -1854.476% |
| aTyr Pharma, Inc. | 13.76 Million USD | -5164.037% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -9074.579% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -2802.98% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -3486.736% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -4831233.333% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -260405.41% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4913.539% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 51.662% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -532090.669% |
| UroGen Pharma Ltd. | 98.55 Million USD | -635.355% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -386.004% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -3700.808% |
| Entera Bio Ltd. | 256 Thousand USD | -282985.938% |
| GH Research PLC | 631 Thousand USD | -114749.445% |
| Lisata Therapeutics, Inc. | 137.00 USD | -528978002.19% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -112781.62% |
| Xencor, Inc. | 14.64 Million USD | -4849.46% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -482226.241% |
| Replimune Group, Inc. | 71.99 Million USD | -906.668% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -483033.333% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -10243.991% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -532090.669% |
| Portage Biotech Inc. | 7000.00 USD | -10352757.143% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -109189.865% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -50613.786% |
| OncoCyte Corporation | 2.2 Million USD | -32781.125% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -1083077.64% |
| Purple Biotech Ltd. | 163 Thousand USD | -444501.227% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -28487.771% |
| scPharmaceuticals Inc. | 38.81 Million USD | -1767.254% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -2770.781% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -992639.726% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -39009.552% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -2650.493% |
| Curis, Inc. | 1.48 Million USD | -48570.248% |
| Daré Bioscience, Inc. | 3.91 Million USD | -18417.118% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -103767.625% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -12078233.333% |
| BeiGene, Ltd. | 197.61 Million USD | -266.718% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -79406.308% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -799.41% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -1296.635% |
| bluebird bio, Inc. | 224.41 Million USD | -222.923% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -22.19% |
| DBV Technologies S.A. | 4.52 Million USD | -15911.931% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -53982.09% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -7338.924% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -19138.121% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -92.094% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -1590.184% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -42107.338% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -77992.672% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -4048.967% |
| MacroGenics, Inc. | 30.19 Million USD | -2299.987% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -3993.656% |
| Prime Medicine, Inc. | 4.35 Million USD | -16533.004% |
| Aditxt, Inc. | 1.04 Million USD | -69466.035% |
| Adagene Inc. | 13.54 Million USD | -5252.276% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -5175.533% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -39.713% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -4139.747% |
| SciSparc Ltd. | 24 Thousand USD | -3019483.333% |
| Vericel Corporation | 81.85 Million USD | -785.335% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -783.599% |
| Generation Bio Co. | 89.77 Million USD | -707.249% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -3166.622% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -259.12% |
| Invivyd, Inc. | 722 Thousand USD | -100273.961% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -1394.165% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -24786730.521% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -18846.405% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -3150769.565% |
| 2seventy bio, Inc. | 244.01 Million USD | -196.992% |
| ADMA Biologics, Inc. | 130.59 Million USD | -454.926% |
| Clene Inc. | 7.15 Million USD | -10032.83% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -21364.586% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -192.67% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -65721.98% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -275592.846% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -276.233% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -2451.491% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -7418.415% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -548.948% |
| Evaxion Biotech A/S | 8.48 Million USD | -8437.183% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -867.234% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -1019.833% |
| Trevena, Inc. | 35.23 Million USD | -1956.878% |
| Surrozen, Inc. | 882 Thousand USD | -82065.533% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -11558.623% |
| Cingulate Inc. | 135.09 Thousand USD | -536321.439% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -2978.72% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -1416.109% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -402511.111% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -2755.51% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -4056.105% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -77325.214% |
| Statera Biopharma, Inc. | 11.43 Million USD | -6239.7% |
| ImmunityBio, Inc. | 836.95 Million USD | 13.412% |
| Korro Bio, Inc. | 31.21 Million USD | -2221.566% |
| Kineta, Inc. | 150 Thousand USD | -483033.333% |
| BioVie Inc. | 349.89 Thousand USD | -207019.871% |
| Codexis, Inc. | 12.24 Million USD | -5819.301% |
| Celularity Inc. | 26.17 Million USD | -2668.461% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -1423.92% |
| Celcuity Inc. | 37.03 Million USD | -1856.776% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -410855.797% |
| Cibus, Inc. | 17.67 Million USD | -4000.373% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -21347.174% |
| Kodiak Sciences Inc. | 100 Million USD | -624.7% |
| Annexon, Inc. | 29.19 Million USD | -2382.7% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -1021.358% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -64490.018% |
| Avalo Therapeutics, Inc. | 2 Million USD | -36135.0% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 48.25% |
| Eyenovia, Inc. | 8.95 Million USD | -7990.67% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -1003.733% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -8800.761% |
| Arcellx, Inc. | 50.84 Million USD | -1325.424% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -49605.075% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -3312.28% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -68591.943% |
| Moolec Science SA | 99.04 Thousand USD | -731580.229% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -2523.728% |
| Geron Corporation | 35.05 Million USD | -1967.559% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -122522.673% |
| Royalty Pharma plc | 6.13 Billion USD | 88.188% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -44035.201% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -2282994.953% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -3030.724% |
| Humacyte, Inc. | 38.6 Million USD | -1777.461% |
| Structure Therapeutics Inc. | 4.01 Million USD | -17958.809% |
| 89bio, Inc. | 24.79 Million USD | -2822.767% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -5728.374% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -38737.085% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -70122.868% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -628.283% |
| Notable Labs, Ltd. | 1.52 Million USD | -47390.17% |
| Liquidia Corporation | 2.36 Million USD | -30555.668% |
| Mustang Bio, Inc. | 1.97 Million USD | -36538.018% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -5175.533% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -10322.839% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -228511.987% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -1352.974% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -7445.814% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -1106498.055% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -532767.647% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -11469.285% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -557361.538% |
| PepGen Inc. | 17.1 Million USD | -4138.012% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -152790.295% |
| United Therapeutics Corporation | 300 Million USD | -141.567% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -2927.025% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -17308.738% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -125280.623% |
| XOMA Corporation | 118.51 Million USD | -511.468% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -1958548.649% |
| Bionomics Limited | 117.62 Million USD | -516.095% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -77574.169% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -12818.004% |
| uniQure N.V. | 130.06 Million USD | -457.183% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -1136.9% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -105541.399% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -16609.707% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -52224.91% |
| Altimmune, Inc. | 175 Thousand USD | -414014.286% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -86.847% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -12818.004% |
| Compugen Ltd. | 719 Thousand USD | -100692.768% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -14205.172% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -757.075% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -7198.087% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -11260.715% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -692.802% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -7198.087% |
| Instil Bio, Inc. | 81.42 Million USD | -790.0% |
| argenx SE | 15.35 Million USD | -4619.943% |
| Immunome, Inc. | 1.34 Million USD | -53982.09% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -135105.224% |
| Verona Pharma plc | 48.37 Million USD | -1398.119% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -7763.498% |
| Shattuck Labs, Inc. | 3.4 Million USD | -21177.158% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -852488.235% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -431269.048% |
| Moolec Science SA | 99.04 Thousand USD | -731580.229% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -6469.032% |
| AnaptysBio, Inc. | 16.03 Million USD | -4418.925% |
| Design Therapeutics, Inc. | 2.33 Million USD | -30949.7% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -2676934.465% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -11978.333% |
| Achilles Therapeutics plc | 1.07 Million USD | -67251.301% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -7763.498% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -3635032.424% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -4228.523% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -907749.573% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -9713075.178% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -5574515.385% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -111.602% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -2859.892% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -28888.116% |
| Palisade Bio, Inc. | 90 Thousand USD | -805122.222% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -373456.701% |
| Beam Therapeutics Inc. | 159.91 Million USD | -353.19% |
| Neurogene Inc. | 13.37 Million USD | -5319.128% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -136.505% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -2659.395% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -1211327.234% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -72370.0% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -1689.029% |
| Athira Pharma, Inc. | 1.21 Million USD | -59448.069% |
| Vaccinex, Inc. | 26 Thousand USD | -2787207.692% |
| HCW Biologics Inc. | 6.3 Million USD | -11395.296% |
| XOMA Corporation | 118.51 Million USD | -511.468% |
| Nektar Therapeutics | 112.62 Million USD | -543.463% |
| Arvinas, Inc. | 800 Thousand USD | -90487.5% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -4913.539% |
| Merus N.V. | 10.48 Million USD | -6809.802% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -4768.66% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -5296.53% |
| Rezolute, Inc. | 1.66 Million USD | -43556.627% |
| Clene Inc. | 7.15 Million USD | -10032.83% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -987929.667% |
| BeyondSpring Inc. | 3.36 Million USD | -21442.806% |
| Synlogic, Inc. | 12.49 Million USD | -5701.777% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -2119.194% |
| Krystal Biotech, Inc. | 6.62 Million USD | -10847.13% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -324.002% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -11986.391% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -1529738.931% |
| MannKind Corporation | 252.15 Million USD | -187.407% |
| Ikena Oncology, Inc. | 7.18 Million USD | -9993.315% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -364070.854% |
| Gossamer Bio, Inc. | 197.4 Million USD | -267.113% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -139265.385% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -157.6% |
| Mural Oncology plc | 8.91 Million USD | -8032.645% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -1556.987% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -50366.574% |
| Champions Oncology, Inc. | 6.09 Million USD | -11793.977% |
| REGENXBIO Inc. | 82.22 Million USD | -781.394% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -146599.514% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -16244.159% |
| Vaxart, Inc. | 2.62 Million USD | -27528.669% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -266695.763% |
| Cellectis S.A. | 36.24 Million USD | -1899.669% |
| Longeveron Inc. | 1.44 Million USD | -49948.343% |
| Repare Therapeutics Inc. | 1.01 Million USD | -71652.475% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 36.01% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -1518.754% |
| Revolution Medicines, Inc. | 80.57 Million USD | -799.41% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -22490.399% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -409335.028% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -589086.992% |
| Denali Therapeutics Inc. | 44.98 Million USD | -1511.125% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -5695.629% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -536321.439% |
| Passage Bio, Inc. | 22.92 Million USD | -3061.729% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -11900.331% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -111909.274% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -3493.851% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -147797.959% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -177759.259% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -60901.684% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -155415.021% |
| OmniAb, Inc. | 22.07 Million USD | -3182.899% |
| Anew Medical, Inc. | 1.54 Million USD | -46958.442% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -2351.625% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -7922.805% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -2230.975% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -17775.025% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -1305.629% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -11282.127% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -5029.167% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -107742.262% |
| Alumis Inc. Common Stock | 30.86 Million USD | -2248.347% |
| Equillium, Inc. | 384 Thousand USD | -188623.958% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -11666.521% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -379.778% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -1382.641% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -602300.625% |
| Dominari Holdings Inc. | 3.02 Million USD | -23833.289% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -3664998.872% |
| vTv Therapeutics Inc. | 169 Thousand USD | -428716.568% |
| Bio-Techne Corporation | 319 Million USD | -127.179% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -1171.671% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -305.844% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -4603.706% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -5752.378% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -14975.931% |
| Nkarta, Inc. | 82.27 Million USD | -780.88% |
| BioCardia, Inc. | 982 Thousand USD | -73698.371% |
| Iterum Therapeutics plc | 18.95 Million USD | -3723.064% |